Vanguard Group
ONC

Vanguard Group’s BeOne Medicines Ltd ONC Stock Holding History

Vanguard Group’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-85,508
Closed -$11.5M – 4562
2022
Q3 		$11.5M Buy
85,508
+998
+1% +$171K ﹤0.01% 2882
2022
Q2 		$13.7M Buy
84,510
+765
+0.9% +$119K ﹤0.01% 2826
2022
Q1 		$15.8M Buy
83,745
+4,245
+5% +$902K ﹤0.01% 2908
2021
Q4 		$21.5M Sell
79,500
-5,861
-7% -$1.98M ﹤0.01% 2804
2021
Q3 		$31M Buy
85,361
+714
+0.8% +$233K ﹤0.01% 2626
2021
Q2 		$29.1M Sell
84,647
-15,470
-15% -$5.12M ﹤0.01% 2644
2021
Q1 		$34.8M Sell
100,117
-123
-0.1% -$40.7K ﹤0.01% 2502
2020
Q4 		$25.9M Sell
100,240
-23,403
-19% -$6.44M ﹤0.01% 2513
2020
Q3 		$35.4M Buy
123,643
+993
+0.8% +$233K ﹤0.01% 2188
2020
Q2 		$23.1M Sell
122,650
-121,043
-50% -$19.7M ﹤0.01% 2354
2020
Q1 		$30M Sell
243,693
-1,018,860
-81% -$159M ﹤0.01% 2101
2019
Q4 		$209M Buy
1,262,553
+5,420
+0.4% +$901K 0.01% 1360
2019
Q3 		$154M Buy
1,257,133
+14,881
+1% +$1.98M 0.01% 1494
2019
Q2 		$154M Buy
1,242,252
+1,712
+0.1% +$217K 0.01% 1518
2019
Q1 		$164M Buy
1,240,540
+43,244
+4% +$5.83M 0.01% 1458
2018
Q4 		$168M Buy
1,197,296
+133,060
+13% +$17.6M 0.01% 1346
2018
Q3 		$183M Buy
1,064,236
+105,702
+11% +$17.8M 0.01% 1450
2018
Q2 		$147M Sell
958,534
-33,886
-3% -$6.04M 0.01% 1554
2018
Q1 		$167M Buy
992,420
+633,591
+177% +$85.8M 0.01% 1419
2017
Q4 		$35.1M Buy
358,829
+247,947
+224% +$22.7M ﹤0.01% 2245
2017
Q3 		$11.5M Buy
+110,882
New +$8.26M ﹤0.01% 2743

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group's ONC Position: Q4 2022 in Review

Vanguard Group sold out of BeOne Medicines Ltd (ONC) in Q4 2022, closing a stake of 85,508 shares — an estimated $11.5M sold.

Vanguard Group first reported a position in ONC in Q3 2017 and held it in 21 quarters. The position peaked at $209M in Q4 2019. 212 funds tracked by Wall St. Rank hold ONC as of Q4 2022.

  • Vanguard Group reported no remaining BeOne Medicines Ltd position as of Q4 2022 after selling out during the quarter.
  • Vanguard Group sold 85,508 BeOne Medicines Ltd shares in Q4 2022, an estimated $11.5M.
  • Vanguard Group first reported a position in BeOne Medicines Ltd in Q3 2017 and held it in 21 quarters.
  • Vanguard Group's BeOne Medicines Ltd position peaked at $209M in Q4 2019.
  • 212 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2022.

Based on Vanguard Group's 13F filing for Q4 2022, filed 10 Feb 2023.